Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy

SM Kim, SH Lee, YG Kim, SY Kim… - American Journal …, 2015 - journals.physiology.org
IL-1β-secreting nucleotide-binding oligomerization domain protein 3 (NLRP3)
inflammasomes play a pivotal role in triggering innate immune responses in metabolic …

The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy

L Wen, H Yang, L Ma, P Fu - Molecular and Cellular Biochemistry, 2021 - Springer
Hyperuricemic nephropathy (HN) is a common clinical complication of hyperuricemia. High-
serum uric acid can trigger renal inflammation. The inflammasome family has several …

Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease

M Wang, X Lin, X Yang, Y Yang - Renal failure, 2022 - Taylor & Francis
Hyperuricemia is an independent risk factor for the progression of chronic kidney disease.
High levels of uric acid can lead to a series of pathological conditions, such as gout, urinary …

High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS/TXNIP pathway in mesangial cells

H Feng, J Gu, F Gou, W Huang, C Gao… - Journal of Diabetes …, 2016 - Wiley Online Library
While inflammation is considered a central component in the development in diabetic
nephropathy, the mechanism remains unclear. The NLRP3 inflammasome acts as both a …

Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy

M Wu, Z Yang, C Zhang, Y Shi, W Han, S Song, L Mu… - Metabolism, 2021 - Elsevier
Background Nucleotide leukin-rich polypeptide 3 (NLRP3) inflammasome is documented as
a potent target for treating metabolic diseases and inflammatory disorders. Our recent work …

Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy

Y Qiu, L Tang - Pharmacological Research, 2016 - Elsevier
Diabetic nephropathy (DN) is a serious complication of diabetes mellitus, and persistent
inflammation in circulatory and renal tissues is an important pathophysiological basis for DN …

[HTML][HTML] Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy

K Shahzad, F Bock, W Dong, H Wang, S Kopf, S Kohli… - Kidney international, 2015 - Elsevier
Diabetic nephropathy is a growing health concern with characteristic sterile inflammation. As
the underlying mechanisms of this inflammation remain poorly defined, specific therapies …

[HTML][HTML] Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease

K Shahzad, S Fatima, H Khawaja, A Elwakiel, I Gadi… - Kidney International, 2022 - Elsevier
Efficient therapies for diabetic kidney disease (DKD), now the leading cause of kidney
failure, are lacking. One hallmark of DKD is sterile inflammation (inflammation in absence of …

The role of the NLRP3 inflammasome in mediating glomerular and tubular injury in diabetic nephropathy

BM Williams, CL Cliff, K Lee, PE Squires… - Frontiers in …, 2022 - frontiersin.org
The NOD-like receptor protein 3 (NLRP3) inflammasome is a multi-protein signalling
complex integral to the chronic inflammatory response, activated in response to sterile and …

NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice

M Wu, W Han, S Song, Y Du, C Liu, N Chen… - Molecular and cellular …, 2018 - Elsevier
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. Activation of the
nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing …